FDA Clears CryoLife’s New HeRO Dialysis Device

CryoLife Receives FDA Clearance For Next Generation HeRO Device (via PR Newswire)

New Adaptor Allows Use with Early Access Arterial Grafts ATLANTA, April 4, 2013 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has received U.S. Food and Drug Administration (FDA) 510…